Dry powder inhalers and the risk of error

Respiration

Volumn 75, Issue 1, 2008, Pages 14-15

  Terzano, Claudio ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

AEROSOL; AIRFLOW; BREATHING; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DEVICE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRY POWDER; EDITORIAL; EQUIPMENT DESIGN; ERGONOMICS; FLOW RATE; INHALATION; MEDICAL PARAMETERS; MEDICATION ERROR; METERED DOSE INHALER; POWDER INHALER; PRIORITY JOURNAL; RISK ASSESSMENT;

ADMINISTRATION, INHALATION; AEROSOLS; ASTHMA; EQUIPMENT FAILURE; EQUIPMENT SAFETY; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; POWDERS; RISK ASSESSMENT;

EID: 38049057280     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111774     Document Type: Editorial

References (11)

1. Wieshammer S, Dreyhaupt J: Dry powder inhalers: which factors determine the frequency of handling errors? Respiration 2008;75:18-25.
2. Timsina MP, Martin GP, Marriott C, Ganderton D, Yianneskis M: Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm 1994;101:1-13.
3. Newman SP: Optimizing delivery of drugs to the lungs. Clin Asthma Rev 1998;2:123-128.
4. Terzano C, Colombo P: State of the art and new perspectives on dry powder inhalers. Eur Rev Med Pharmacol Sci 1999;3:247-254.
5. De Boer AH, Bolhuis GK, Gjaltema D, Hagedoorn P: Inhalation characteristics and their effect on in vitro drug delivery from dry powder inhalers. 3. The effect of flow increase rate (FIR) on the in vitro drug release from Pulmicort 200 Turbuhaler. Int J Pharm 1997;153:67-77.
6. Broeders ME, Molema J, Hop WC, Folgering HT: Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction. J Aerosol Med 2003;16:131-141.
7. De Boer AH, Winter HMI, Lerk CF: Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. 1. Inhalation characteristics, work of breathing and volunteers' preference in dependence of the inhaler resistance. Int J Pharm 1996;130:231-244.
8. Vidgren M, Karkkainen A, Karjalainen P, Paronen P, Nuutinen J: Effect of powder inhaler design on drug deposition in the respiratory tract. Int J Pharm 1988;42:211-216.
9. Hickey AJ, Gonda I, Irwin WJ, Fildes FJT: Factors influencing the dispersion of dry powders as aerosols. J Pharm Sci 1990;79:1009-1014.
10. Terzano C: Pressurized metered dose inhalers and add-on devices. Pulm Pharmacol Ther 2001;14:351-366.
11. Schmid G, Cardaci V, Chambers CB, Nantel N, Newhouse MT: Patient compliance in using the Pulmicort Turbuhaler. Am J Respir Crit Care Med 1997;155:A568.